FDA Grants Fast Track Designation to EO2463 for Follicular Lymphoma The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to EO2463, a novel immunotherapy from Enterome, aimed at treating follicular lymphoma (FL), a common indolent form of non-Hodgkin lymphoma (NHL). This decision is based on encouraging interim results from the ongoing phase…